Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results tomorrow afternoon. Here’s what to look for. Vertex Pharmaceuticals beat analysts’ revenue expectations by 3.2% ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q4 CY2024 results exceeding the market’s revenue expectations , with sales up 15.7% year on year to $2.91 billion. The company ...

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published ...

In a report released yesterday, Jessica Fye from J.P. Morgan maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $501.00. The company’s shares ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

I need to make amends for that sometime. Before we begin, I’ve set up a discussion group for Connections and this column on Discord. You can chat about each game (and other topics) with me and ...

As one of the most versatile laptops on the market, Dell's XPS 16 (2024) is also one of the best-designed. Its zero-lattice keyboard and brilliant 4K OLED display make for a striking first ...

I hope to visit you again someday. Before we begin, I’ve set up a discussion group for Connections and this column on Discord. You can chat about each game (and other topics) with me and other ...